In this randomized clinical trial, the use of near-infrared spectroscopy and hemodynamic monitoring did not provide ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body to create a new route for blood to flow around blocked arteries. It is ...

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...

Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital in Ocean Breeze has been recognized with the highest ...

Researchers from Philadelphia-based University of Pennsylvania’s Leonard Davis Institute of Health Economics recently found ...

The following is a summary of "Transit time flow management as a management strategy in high-risk groups undergoing coronary ...

Early CABG surgery post-ticagrelor is noninferior to delayed surgery for perioperative bleeding and may reduce hospital stay ...

Type 2 diabetes patients who have undergone coronary artery bypass surgery have a high risk of death and complications if their blood sugar is not well controlled. In the midst of this, a real-time ...

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...

PTAB with the DETOUR System offers a novel approach to treating complex peripheral arterial disease (PAD), enabling physicians to percutaneously bypass lesions in the superficial femoral artery by ...